Author:
Milak M S,Proper C J,Mulhern S T,Parter A L,Kegeles L S,Ogden R T,Mao X,Rodriguez C I,Oquendo M A,Suckow R F,Cooper T B,Keilp J G,Shungu D C,Mann J J
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference95 articles.
1. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959–964.
2. Homayoun H, Moghaddam B . NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neuroimmune Pharmacol 2007; 27: 11496–11500.
3. McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW . A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med 2014; 1–12.
4. Fond G, Loundou A, Rabu C, Macgregor A, Lancon C, Brittner M et al. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology 2014; 231: 3663–3676.
5. Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856–864.
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献